Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

Abstract
Key Points. Allogeneic CD19-CAR VSTs are well tolerated by patients with relapsed B-cell malignancies post-HSCT.At periods of CD19-CAR VST persistence, these c

This publication has 41 references indexed in Scilit: